載入...
SAT-474 Giant Prolactinoma Case Series Assessing Response on Initial Dose of Cabergoline
Background: Giant prolactinomas (GPs) are rare representing 2-3% of prolactinomas and only ~ 0.5% of all pituitary tumors. Various definitions have been proposed for GP but commonly accepted criteria is tumor dimension of ≥4 cm. GP is often associated with very high prolactin (PRL) ranging 1,000 -10...
Na minha lista:
| 發表在: | J Endocr Soc |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Endocrine Society
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552231/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-474 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|